CIK: 0001538653 · Show all filings
Period: Q2 2024 (← Previous) (Next →)
Filing Date: Aug 14, 2024
Total Value ($000): $1,634,747 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CACC | CREDIT ACCEP CORP MICH | 1,560,014 | $802,908 | 49.1% | $107.75 | +372.7% | COM | 225310101 |
| CMPR | CIMPRESS PLC | 3,906,492 | $342,248 | 20.9% | $129.96 | -32.9% | SHS EURO | G2143T103 |
| WRLD | WORLD ACCEP CORP DEL | 2,037,495 | $251,794 | 15.4% | $81.92 | +60.9% | COM | 981419104 |
| W | WAYFAIR INC | 3,752,264 | $197,857 | 12.1% | $53.95 | +10.1% | CL A | 94419L101 |
| YELP | YELP INC | 796,371 | $29,426 | 1.8% | $30.67 | +24.9% | CL A | 985817105 |
| BTI | BRITISH AMERN TOB PLC | 200,000 | $6,186 | 0.4% | $30.93 | — | SPONSORED ADR | 110448107 |
| PM | PHILIP MORRIS INTL INC | 28,000 | $2,837 | 0.2% | $91.29 | 0.0% | COM | 718172109 |
| POWW | AMMO INC | 520,000 | $874 | 0.1% | $2.41 | 0.0% | COM | 00175J107 |
| LCTX | LINEAGE CELL THERAPEUTICS IN | 620,000 | $618 | 0.0% | $1.03 | +7.2% | COM | 53566P109 |